XML 81 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments
12 Months Ended
Jun. 30, 2021
Commitments [Abstract]  
Commitments

Note 27. Commitments

 

(i)

Lease commitments – Group as lessee

Lease commitments are in respect of low value leases which have not been recognized in the Statement of Financial Position. These leases are expensed on a straight‑line basis over the term of the lease.

 

 

 

 

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

 

 

 

 

Restated

 

 

Restated

 

 

 

US$

 

 

US$

 

 

US$

 

Within one year

 

 

5,304

 

 

 

4,497

 

 

 

4,936

 

After one year but not more than five years

 

 

8,398

 

 

 

11,619

 

 

 

—

 

 

 

 

13,702

 

 

 

16,116

 

 

 

4,936

 

 

 

(ii)

Research projects and license commitments

The Group has entered into research and development contracts and intellectual property license agreements with various third parties in respect of services for the Phase 3 DME clinical trial and the clinical grade manufacture of OPT‑302. Expenditure commitments relating to these and intellectual property license agreements are payable as follows:

 

 

 

 

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

 

 

 

 

Restated

 

 

Restated

 

 

 

US$

 

 

US$

 

 

US$

 

Within one year

 

 

26,377,778

 

 

 

7,660,325

 

 

 

5,460,972

 

After one year but not more than five years

 

 

2,347,060

 

 

 

293,815

 

 

 

60,000

 

After more than five years

 

 

—

 

 

 

75,000

 

 

 

90,000

 

 

 

 

28,724,838

 

 

 

8,029,140

 

 

 

5,610,972

 

 

Currently, the biggest Research contract has a 60 day termination clause and all commitments have been limited to a six month commitment.